Search results
AstraZeneca Is Withdrawing Its Covid Vaccine Worldwide, Citing Low Demand
New York Times· 3 hours agoThe shot is no longer being manufactured or supplied, and it is no longer authorized for use in...
European Medicines Agency pulls authorization for AstraZeneca’s COVID shot, at company’s request
FOX 59 Indianapolis· 9 hours agoLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
European Medicines Agency pulls authorization for AstraZeneca’s COVID shot, at company’s request
WDTN-TV 2 Dayton· 9 hours agoLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
ERC Updates: Handling The Flood Of Improper Claims
Forbes· 2 days agoMary Wood of Meadows Collier discusses recent updates on the employee retention credit, from the IRS’s moratorium on new claims to the potential effect...
Is Zoom Video A Buy As Microsoft Unbundles Teams, Office Tools?
Investor's Business Daily· 2 days agoThat rating analyzes price and volume changes in a stock over the past 13 weeks of trading. Its...
AstraZeneca withdraws COVID-19 vaccine, citing lack of demand
Seattle Times· 9 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Alzheimer’s is 7th-leading cause of death in Ohio, says recent report
The Cleveland Plain Dealer· 6 hours agoMore than 236,000 Ohioans 65 or older — or about 11% of Ohio seniors — are living with Alzheimer’s...
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
RTT News· 11 hours agoMeanwhile, AstraZeneca reportedly had admitted recently in court documents that the vaccine could cause side-effects such as blood clots and low blood platelet counts. The latest move follows ...
New COVID-19 variant FLiRT detected in US. Here's what to know
The El Paso Times via Yahoo News· 5 hours agoLatest COVID guidance from the CDC In March 2024, the CDC updated its COVID-19 guidance so people...
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
CNBC· 4 hours agoDemand for AstraZeneca's Vaxzevria vaccine began tapering off as new vaccines tailored to specific...